MedTrace Logo

Prospective Assessment of Quality of Life in Patients Treated by Radiosurgery for Brain Metastases (PRAMECE-1302)

NCT02565433 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2026-03-16

No results posted yet for this study

Summary

The aim of the study is to assess prospectively the impact of radiosurgery on the quality of life in patients with brain metastases.

Conditions

  • Neoplasm Metastases

Interventions

OTHER

questionnaire administration

Within 15 days before radiosurgery and then at 3, 6, 9, 12 months after radiosurgery, the patients who have accepted to participate will have to complete these questionnaires : QLQC30, BN20, IADL, HADS, MoCa, Edmonton Symptom Assessment Scale

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Besancon

    collaborator OTHER

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Emilie Le Rhun, MD · Centre Oscar Lambret

  • Franck Bonnetain, MD · CHRU de Besançon

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-05
Primary Completion
2018-01-31
Completion
2018-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02565433 on ClinicalTrials.gov